Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Preaxia Health Care Payment Systems (PAXH) Net Income towards Common Stockholders (2019 - 2025)

Preaxia Health Care Payment Systems' Net Income towards Common Stockholders history spans 7 years, with the latest figure at $1.7 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 12799.96% to $1.7 million in Q4 2025 year-over-year; TTM through Nov 2025 was $847207.0, a 2771.4% increase, with the full-year FY2025 number at -$80654.0, up 18.9% from a year prior.
  • Net Income towards Common Stockholders hit $1.7 million in Q4 2025 for Preaxia Health Care Payment Systems, up from -$874906.0 in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for PAXH hit a ceiling of $1.7 million in Q4 2025 and a floor of -$874906.0 in Q3 2025.
  • Historically, Net Income towards Common Stockholders has averaged $16400.8 across 5 years, with a median of -$39715.0 in 2021.
  • The widest YoY moves for Net Income towards Common Stockholders: up 12799.96% in 2025, down 18808.71% in 2025.
  • Tracing PAXH's Net Income towards Common Stockholders over 5 years: stood at -$43655.0 in 2021, then fell by 3.29% to -$45092.0 in 2022, then dropped by 0.04% to -$45109.0 in 2023, then soared by 69.7% to -$13666.0 in 2024, then surged by 12799.96% to $1.7 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for PAXH at $1.7 million in Q4 2025, -$874906.0 in Q3 2025, and -$13463.0 in Q1 2025.